Europe: Food, Drugs, Healthcare, Life Sciences

Subscribe
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
Gaining Ground In The Fight Against Sepsis
Sepsis Awareness Month brings significant developments in the fight against this life-threatening condition, including the extension of Martha's Rule to all hospital emergency departments by March 2028 and promising advances in rapid diagnostic testing. With sepsis affecting 245,000 people annually in the UK and contributing to 48,000 deaths, understanding the symptoms, treatment protocols, and legal implications of delayed diagnosis has never been more critical.
United Kingdom Healthcare
KN
Kingsley Napley
Article
EU Council Adopts New EU Pharma Package
The Council of the EU has adopted the most comprehensive reform of EU pharmaceutical legislation in over 20 years, fundamentally reshaping regulatory protection mechanisms, market exclusivity periods, and incentive structures for pharmaceutical companies. These reforms balance patient access to medicines with creating a more competitive and innovation-friendly environment, addressing antimicrobial resistance, medicine supply challenges, and the early availability of generic alternatives.
Ireland Healthcare
M
Matheson
See more

Healthcare

Article
Cauda Equina Awareness Day 2026: Supporting Clients, Raising Awareness And Making A Difference
Penningtons Manches Cooper's medical negligence team shares their experience supporting clients affected by cauda equina syndrome, highlighting how early intervention and holistic legal support can help rebuild lives following this rare spinal condition. Through case studies and practical examples, the firm demonstrates the transformative impact of securing timely compensation, rehabilitation access, and specialist equipment for CES survivors.
United Kingdom Litigation
PS
Penningtons Manches Cooper LLP
Article
Gaining Ground In The Fight Against Sepsis
Sepsis Awareness Month brings significant developments in the fight against this life-threatening condition, including the extension of Martha's Rule to all hospital emergency departments by March 2028 and promising advances in rapid diagnostic testing. With sepsis affecting 245,000 people annually in the UK and contributing to 48,000 deaths, understanding the symptoms, treatment protocols, and legal implications of delayed diagnosis has never been more critical.
United Kingdom Healthcare
KN
Kingsley Napley
See more

Food and Drugs Law

Article
Life Sciences Patents Monthly Roundup—September 2026
This September edition examines pivotal developments in life sciences patent law across Europe, with the Unified Patent Court continuing to refine its jurisprudence on added matter, intermediary liability, and procedural standards. National courts in the UK, France, and the Netherlands deliver significant rulings on supplementary protection certificates, pro-drugs, and the boundaries of pharmacy exemptions that will shape patent strategy for pharmaceutical and medical device companies.
European Union IP
AO
A&O Shearman
Article
EU Council Adopts New EU Pharma Package
The Council of the EU has adopted the most comprehensive reform of EU pharmaceutical legislation in over 20 years, fundamentally reshaping regulatory protection mechanisms, market exclusivity periods, and incentive structures for pharmaceutical companies. These reforms balance patient access to medicines with creating a more competitive and innovation-friendly environment, addressing antimicrobial resistance, medicine supply challenges, and the early availability of generic alternatives.
Ireland Healthcare
M
Matheson
Article
Borderline Products: Distinguishing Medicinal Products, Medical Devices And Cosmetics Under Turkish Law
A critical consideration before placing health and personal care products on the market is determining their correct regulatory classification. For borderline products – products that may exhibit characteristics of medicinal products, medical devices or cosmetics – this distinction has significant implications for the applicable regulatory requirements, market entry procedures, costs and ongoing compliance obligations.
Turkey Healthcare
P
Paksoy
See more

Life Sciences, Biotechnology & Nanotechnology

Article
Life Sciences Patents Monthly Roundup—September 2026
This September edition examines pivotal developments in life sciences patent law across Europe, with the Unified Patent Court continuing to refine its jurisprudence on added matter, intermediary liability, and procedural standards. National courts in the UK, France, and the Netherlands deliver significant rulings on supplementary protection certificates, pro-drugs, and the boundaries of pharmacy exemptions that will shape patent strategy for pharmaceutical and medical device companies.
European Union IP
AO
A&O Shearman
Article
EU Council Adopts New EU Pharma Package
The Council of the EU has adopted the most comprehensive reform of EU pharmaceutical legislation in over 20 years, fundamentally reshaping regulatory protection mechanisms, market exclusivity periods, and incentive structures for pharmaceutical companies. These reforms balance patient access to medicines with creating a more competitive and innovation-friendly environment, addressing antimicrobial resistance, medicine supply challenges, and the early availability of generic alternatives.
Ireland Healthcare
M
Matheson
See more

Latest Videos

See more